Examination of publicly available lung cancer gene expression datasets [28, 29] revealed that PARP4 expression levels were lower in lung cancer samples than in matched normal tissue (Fig. 1J); this underscored the observation that PARP4 expression is downregulated or lost during lung cancer progression. The gene discussed is PARP4; the disease is lung carcinoma.